• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cardinal Analytx closes $6.1m Series A funding round

Cardinal Analytx closes $6.1m Series A funding round

September 27, 2017 By Alex Beall

New machine learning company Cardinal Analytx closed a $6.1 million Series A financing round to fund the development of its healthcare technology with data science, engineering and clinical capabilities. Investors included Cardinal Partners, Premera Blue Cross and the Stanford-StartX Fund.

To reduce the costs associated with health insurance, the company developed a machine learning platform that uses artificial intelligence-based predictive modeling and intervention recommendations to identify potential high-cost members and provide customized medical recommendations. The information allows care managers and clinical teams to anticipate and prevent situations leading to high healthcare costs like surgeries or hospital stays.

“Unexpected increases in healthcare costs that result from potentially dangerous and expensive medical conditions can have a lasting effect,” CEO Thomas McKinley said in a press release. “Conventional analytic approaches have identified existing high-cost enrollees, but that’s already too late and does not effectively address prevention. Cardinal Analytx’s approach looks for members who are likely to have serious medical events before they occur and then outlines a clinical intervention plan to mitigate escalating health concerns before the onset.”

To test the solution, Cardinal Analytx partnered on a pilot program with Premera Blue Cross to analyze the data from 1.4 million members and predict new high-cost members for the next year. The technology was able to accurately predict individuals who would become high-cost members, 67% of which were not identified by other approaches.

“Cardinal Analytx enabled us to better predict which members could benefit from early interventions and provide effective recommendations to engage them in healthier behaviors,” Premera Blue Cross’s executive vice president of healthcare services Dr. John Espinola said in the statement. “The pilot results were outstanding, compelling us to invest in a team and company that is on the cusp of transforming how we help patients who need it the most.”

The company came out of the Stanford University-affiliated StartX startup accelerator and was founded by doctors and Stanford professors Arnie Milstein and Nigam Shah — whose research found that only 10% of insurance enrollees make up 70% of healthcare spending and that 60% of high-cost members were not high-cost the previous year.

“Our goal is to bring precision to the practice of medicine by coupling a machine’s accuracy with a human’s judgment and intuition,” Shah said.

Filed Under: Funding Roundup, Health Information Technology, Software / IT, Wall Street Beat Tagged With: cardinal analytx

More recent news

  • Medtronic reports first patient treated in study of multi-organ denervation for hypertension
  • Baxter turns to an automation company for its new CEO
  • Pristine Surgical appoints new CFO
  • Boston Scientific wins expanded FDA nod for Farapulse PFA
  • FDA warns on issue with J&J Abiomed pump controllers related to 3 deaths

About Alex Beall

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy